Golden Throat Holdings Group Company Limited (6896.HK)
HKD 4.18
(-0.24%)
HKD 4.18
(-0.24%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.29 Billion CNY | -0.01% |
| 2022 | 2.29 Billion CNY | 17.72% |
| 2021 | 1.95 Billion CNY | 15.91% |
| 2020 | 1.68 Billion CNY | 3.57% |
| 2019 | 1.62 Billion CNY | 9.49% |
| 2018 | 1.48 Billion CNY | 9.09% |
| 2017 | 1.36 Billion CNY | -4.91% |
| 2016 | 1.43 Billion CNY | 10.06% |
| 2015 | 1.3 Billion CNY | 129.12% |
| 2014 | 568.02 Million CNY | -3.84% |
| 2013 | 590.72 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q4 | 2.29 Billion CNY | 17.53% |
| 2023 FY | 2.29 Billion CNY | -0.01% |
| 2023 Q2 | 1.95 Billion CNY | -14.92% |
| 2022 Q4 | 2.29 Billion CNY | 26.01% |
| 2022 FY | 2.29 Billion CNY | 17.72% |
| 2022 Q2 | 1.82 Billion CNY | -6.58% |
| 2021 Q4 | 1.95 Billion CNY | 10.65% |
| 2021 FY | 1.95 Billion CNY | 15.91% |
| 2021 Q2 | 1.76 Billion CNY | 4.76% |
| 2020 Q4 | 1.68 Billion CNY | 10.28% |
| 2020 Q2 | 1.52 Billion CNY | -6.08% |
| 2020 FY | 1.68 Billion CNY | 3.57% |
| 2019 FY | 1.62 Billion CNY | 9.49% |
| 2019 Q2 | 1.72 Billion CNY | 16.32% |
| 2019 Q4 | 1.62 Billion CNY | -5.88% |
| 2018 Q4 | 1.48 Billion CNY | 7.26% |
| 2018 FY | 1.48 Billion CNY | 9.09% |
| 2018 Q2 | 1.38 Billion CNY | 1.71% |
| 2017 Q4 | 1.36 Billion CNY | 5.53% |
| 2017 FY | 1.36 Billion CNY | -4.91% |
| 2017 Q2 | 1.29 Billion CNY | -9.89% |
| 2016 Q2 | 1.4 Billion CNY | 7.78% |
| 2016 Q4 | 1.43 Billion CNY | 2.12% |
| 2016 FY | 1.43 Billion CNY | 10.06% |
| 2015 FY | 1.3 Billion CNY | 129.12% |
| 2015 Q4 | 1.3 Billion CNY | 147.39% |
| 2015 Q2 | 526.07 Million CNY | -7.39% |
| 2014 FY | 568.02 Million CNY | -3.84% |
| 2014 Q4 | 568.02 Million CNY | 0.0% |
| 2013 FY | 590.72 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -153.347% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 89.789% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -78.609% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -9.733% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -380.852% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | 20.467% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | 18.692% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -33.097% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -172.41% |
| SSY Group Limited | 11.96 Billion HKD | 80.787% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -65.554% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 34.066% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 99.154% |